Skip to main content

Table 5 Objective and subjective outcome measures captured in the review

From: The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature

Outcome name

Shift workers

Jet lag

Insomnia

Initiation of Sleep/Sleep efficacy

Daytime sleepiness (occurrence of)/Somnolence

Phase shift/hormone changes

Objective measures

Polysomnographic recording (PSG)*; Actigraph*; Saliva samples**; Blood samples**; Electroencephalogram (EEG)*; Accelerometers*; Hours of sleep*; Heart rate/Heart rate variability (HR/HRV)*; Melatonin assays*; Multiple sleep latency test(MSLT)*; Urine samples**; 5- min reaction test*

7

6

2

9

1

9

Subjective measures

Visual Analog Scale (VAS)*; Sleep diaries; Stanford Sleepiness Scale (SSS)*; Profile of Mood States (POMS)*; Karolinska Sleepiness Scale (KSS)*; Daily Sleep Questionnaire (DSQ); Questionnaire; 7 point Likert Drowsiness Scale; Accumulated Time with Sleepiness Scale (ATS)*; Accumulated Time with Sleepiness Scale (ATS)*; Bond-Lader Questionnaire; Columbia Jet Lag Scale*; Daily Subjective Sleep Experiencing Questionnaire (DSSEQ); Leeds Sleep Evaluation Questionnaire*; Linear Sleepiness Rating; Pittsburgh Sleep Quality Index (PSQI)*; Retrospective ratings; Subjective Sleep Quality Questionnaire; Symptom assessments; Symptom questionnaire

21

24

8

5

6

3

  1. *Validated Measures.
  2. **Objective measures captured to determine melatonin bioavailability but not relevant outcomes of interest to this review.